Low-intensity shockwave therapy (LiST) for erectile dysfunction: a randomized clinical trial assessing the impact of energy flux density (EFD) and frequency of sessions

The impact of energy flux density (EFD) used on low-intensity shockwave therapy (LiST) for erectile dysfunction (ED) has not been explored. Our aim was to compare EFD 0.05 versus 0.10 mJ/mm 2 regarding efficacy and safety of 12-treatment sessions when applied two or three times per week. Ninety-seve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of impotence research 2020-05, Vol.32 (3), p.329-337
Hauptverfasser: Kalyvianakis, Dimitrios, Mykoniatis, Ioannis, Memmos, Evangelos, Kapoteli, Paraskevi, Memmos, Dimitrios, Hatzichristou, Dimitrios
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The impact of energy flux density (EFD) used on low-intensity shockwave therapy (LiST) for erectile dysfunction (ED) has not been explored. Our aim was to compare EFD 0.05 versus 0.10 mJ/mm 2 regarding efficacy and safety of 12-treatment sessions when applied two or three times per week. Ninety-seven patients with vasculogenic ED, PDE5 inhibitors users were randomized into four groups, to receive 12 LiST sessions. Group A ( n  = 24) : two sessions per week, EFD 0.05 mJ/mm 2 ; Group B ( n  = 24): three sessions per week, EFD 0.05 mJ/mm 2 ; Group C ( n  = 24): two sessions per week, EFD 0.10 mJ/mm 2 ; Group D ( n  = 25): three sessions per week, EFD 0.10 mJ/mm 2 . International Index for Erectile Function—Erectile Function domain (IIEF-EF), Minimally clinical important differences (MCID), sexual encounter profile, and triplex ultrasonography parameters were used to asses erectile function. Eighty-nine patients completed the 6-month follow-up (FU). All four groups improved in mean IIEF-EF score, average SEP3 “Yes” response rates at 6-month FU visit compared with baseline ( p  
ISSN:0955-9930
1476-5489
DOI:10.1038/s41443-019-0185-0